7670.T

The company maintains a conservative capital structure with a debt-to-equity ratio of 0.18, indicating a low reliance on debt financing. Its liquidity position is strong, with a current ratio of 1.52 and cash and equivalents amounting to 6.545 billion JPY. The price-to-book ratio of 0.49 suggests the company is trading at a discount to its book value, potentially reflecting market skepticism about its asset quality or future earnings potential.

Profitability metrics show a return on equity of 8.33% and a return on assets of 3.88%, both below the typical thresholds for high-performing chemical firms. The operating margin of 1.79% (calculated from operating income of 1.239 billion JPY on revenue of 69.416 billion JPY) is significantly lower than the industry median, indicating operational inefficiencies or pricing pressures. The company's gross margin of 13.16% (calculated from gross profit of 9.135 billion JPY) is also below the industry average, suggesting cost management challenges.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific revenue data limits the ability to assess the performance of different product lines or markets.

The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The outlook for the current fiscal year is neutral, with no projected changes in revenue or earnings. The company's capital expenditure of -153 million JPY indicates a reduction in investment, which may signal a focus on cost containment rather than expansion.

Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt levels and strong cash reserves mitigate credit risk, but the low return on equity and operating margin suggest potential earnings volatility. The absence of dilution risk is a positive factor, but the company's conservative capital structure may limit its ability to capitalize on growth opportunities.

Recent events include the latest actual EPS of 173.89 JPY and revenue of 69.416 billion JPY, aligning with analyst estimates. No significant filings or transcripts were disclosed in the provided data, limiting insight into recent strategic developments or management commentary.